Featured Stories

Please reserve for your seat at the below eventbrite link for free. https://www.eventbrite.com/e/novel-therapeutic-targets-in-both-breast-and-kidney-cancers-tickets-119195604261 Hypoxia is associated with resistance towards radiation and chemotherapy. As tumors grow, they can sense the oxygen tension and reprogram critical pathways that are important for cancer cell survival and therapy resistance. One of examples is through upregulation of hypoxia inducible factorRead more

Metabolite identification (MetID) plays an important role in drug discovery and development process. During the lead optimization stage, early MetID study can help identify the metabolic “soft spots”, so medicinal chemists can make appropriate structure modification to improve the pharmacokinetic properties of the compounds. During the IND-enabling stage, the information obtained from cross-species metabolite profilingRead more

Yichang, Hubei, Aug 13, 2020 – A seminar on preclinical R&D strategic cooperation was held between Medicilon. INC (Stock Code: 688202. SH) and Yichang Humanwell Pharmaceutical CO.LTD (Stock Code: 600079. SH). During the meeting, the two companies discussed the vision of cooperation in the future, hoping to strengthen the relationship, jointly promote the research andRead more

Medicilon will exhibit the ACS Fall 2020 Virtual Meeting & Expo from Aug 17-20.  Please visit https://calendly.com/fywang to schedule a 1-on-1 meeting with our VP of Business Development, Dr. Frank Wang, for our chemistry study.  We look forward to see you.Read more

“ADME” means “toxic pharmacokinetics”, which is the study of the body’s absorption, distribution, metabolism and excretion of foreign chemicals. Medicilon Drug Safety Evaluation Service》》 Toxicokinetic absorption, distribution, metabolism, excretion The toxicokinetic study adopts repeated administration toxicity test dose to study the dynamic change law of the drug in the body and obtain pharmacokinetic data. UsuallyRead more